The role of vasopressin in the treatment of vasodilation in shock states

Annals of Pharmacotherapy

Volumn 34, Issue 2, 2000, Pages 250-254

  Rozenfeld, Vitalina ^a,b   Cheng, Judy WM ^c,d  

^a LONG ISLAND UNIVERSITY   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d Arnold and Marie Schwartz College of Pharmacy   (United States)

Author keywords

Shock; Vasopressin

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; VASOPRESSIN;

ARTICLE; HEART ARREST; HEART FAILURE; MEAN ARTERIAL PRESSURE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SEPTIC SHOCK; SHOCK; SMOOTH MUSCLE; TREATMENT OUTCOME; VASODILATATION;

EID: 0033950736     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19066     Document Type: Article

References (20)

1. Reid IA. Role of vasopressin deficiency in the vasodilation of septic shock. Circulation 1997;95:1108-10.
2. Mohring J, Glanzer K, Maciel JA Jr, Dusing R, Kramer HJ, Arbogast R, et al. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol 1980;2:367-76.
3. Luk J, Ajaelo I, Wong V, Chang D, Chou L, Reid IA. Role of V1-receptors in the action of vasopressin on the baroreflex control of heart. Am J Physiol 1993;265:R524-9.
4. Schwartz J, Keil LC, Maselli J, Reid IA. Role of vasopressin in blood pressure regulation during adrenal insufficiency. Endocrinology 1983; 112:234-8.
5. Undesser KP, Hasser EN, Haywood JR, Johnson AK, Bishop VS. Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res 1985;56:410-7.
6. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL. Cunnion RE, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-42.
7. Johnson S, Record K, DiPiro J. Gram negative sepsis and septic shock. In: DiPiro J, Talbert R, editors. Pharmacotherapy: a pathophysiological approach. 3rd ed. Stamford, CT: Appleton & Lange, 1997:2237-50.
8. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993;7:563-73.
9. Weitzberg E, Lunberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991;33:222-7.
10. Lindner KH, Haak T, Keller A, Bothner U, Lurie KG. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996;75:145-50.
11. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992;77:662-8.
12. Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-6.
13. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 1986;18:141-55.
14. Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-5.
15. Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, Landry DW. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assisted device placement. Circulation 1997;96(suppl II):286-90.
16. Chugh SS, Lurie KG, Lindner KH. Presser with promise: using vasopressin in cardiopulmonary arrest. Circulation 1997;96:2453-4.
17. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82.
18. Malay MB, Ashton RC, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory shock. J Trauma 1999;47:699-703.
19. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998;116:973-80.
20. Rector WG, Hossack KF. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. J Hepatol 1989;8:308-15.